Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 10, Issue 24, 2004, Pages 3569-3573

  Yang, Lian Yue ^a   Wang, Wei ^a   Peng, Ji Xiang ^a   Yang, Jie Quan ^a   Huang, Gen Wen ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; COMPLEMENTARY DNA; DNA; MESSENGER RNA; RNA;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CANCER INVASION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DOWN REGULATION; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; METASTASIS POTENTIAL; MOLECULAR MECHANICS; NICK END LABELING; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR VOLUME; UPREGULATION;

EID: 10244222818     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i24.3569     Document Type: Article

References (33)

1. Okuda K. Hepatocellular carcinoma: clinicopathological aspects. J Gastroenterol Hepatol 1997; 12: S314-318
2. Huang G, Yang L, Yang J, Liu H, Yang Z. Correlation between epidermal growth factor and overexpression of vascular endothelial growth factor in hepatocellular carcinoma. Zhonghua Zhongliu Zazhi 2002; 24: 564-566
3. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537
4. Cherepinsky V, Feng J, Rejali M, Mishra B. Shrinkage-based similarity metric for cluster analysis of microarray data. Proc Natl Acad Sci U S A 2003; 100: 9668-9673
5. King HC, Sinha AA. Gene expression profile analysis by DNA microarrays: promise and pitfalls. JAMA 2001; 286: 2280-2288
6. Schena M. Genome analysis with gene expression microarrays. Bioessays 1996; 18: 427-431
7. Suwa H, Ohshio G, Imamura T, Watanabe G, Arii S, Imamura M, Narumiya S, Hiai H, Fukumoto M. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 1998; 77: 147-152
8. Poon RT, Fan ST. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am 2003; 12: 35-50
9. Atkins KB, Troen BR. Phorbol ester stimulated cathepsin L expression in U937 cells. Cell Growth Differ 1995; 6: 713-718
10. Niedergethmann M, Hildenbrand R, Wolf G, Verbeke CS, Richter A, Post S. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection. Int J Pancreatol 2000; 28: 31-39
11. Hourihan RN, O'Sullivan GC, Morgan JG. Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 2003; 23: 161-165
12. Takeuchi T, Liang SB, Matsuyoshi N, Zhou S, Miyachi Y, Sonobe H, Ohtsuki Y. Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest 2002; 82: 1023-1029
13. Okazaki N, Takahashi N, Kojima S, Masuho Y, Koga H. Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis 2002; 23: 1139-1148
14. Chen MW, Vacherot F, De La Taille A, Gil-Diez-De-Medina S, Shen R, Friedman RA, Burchardt M, Chopin DK, Buttyan R. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells. Oncogene 2002; 21 7861-7871
15. Wolverton T, Lalande M. Identification and characterization of three members of a novel subclass of protocadherins. Genomics 2001; 76: 66-72
16. Suzuki ST. Recent progress in protocadherin research. Exp Cell Res 2000; 261: 13-18
17. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, Konishi I. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 2003; 83 861-870
18. Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ. Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 2003; 9: 1950-1953
19. Donald CD, Cooper CR, Harris-Hooker S, Emmett N, Scanlon M, Cooke DB 3rd. Cytoskeletal organization and cell motility correlates with metastatic potential and state of differentiation in prostate cancer. Cell Mol Biol 2001; 47: 1033-1038
20. Ridley AJ. Rho GTPases and cell migration. J Cell Sci 2001; 114 (Pt 15): 2713-2722
21. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000; 406: 532-535
22. Zondag GC, Evers EE, ten Klooster JP, Janssen L, van der Kammen RA, Collard JG. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J Cell Biol 2000; 149: 775-782
23. Matsumoto H, Nagao M, Ogawa S, Kanehiro H, Hisanaga M, Ko S, Ikeda N, Fujii H, Koyama F, Mukogawa T, Nakajima Y. Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas. Anticancer Res 2003; 23: 1333-1341
24. Neef R, Kuske MA, Prols E, Johnson JP. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res 2002; 62: 5920-5929
25. Bhoumik A, Huang TG, Ivanov V, Gangi L, Qiao RF, Woo SL, Chen SH, Ronai Z. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 2002; 110: 643-650
26. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825
27. Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc'h N, Pold M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J 2004; 18: 206-208
28. Yamada Y, Kuroiwa T, Nakagawa T, Kajimoto Y, Dohi T, Azuma H, Tsuji M, Kami K, Miyatake S. Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg 2003; 99: 738-745
29. Lo Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De Rosa G, Kudo Y, Takata T, Altieri DC. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 2003; 82: 923-928
30. Yang L, Cao Z, Yan H, Wood WC. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003; 63: 6815-6824
31. Grabowski P, Scherubl H. Survivin - an anti-apoptosis protein. Med Sci Monit 2003; 9: LE25
32. Bussey KJ, Lawce HJ, Himoe E, Shu XO, Heerema NA, Perlman EJ, Olson SB, Magenis RE. SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development. Genes Chromosomes Cancer 2001; 32: 342-352
33. Hisaoka M, Sheng WQ, Tanaka A, Hashimoto H. Gene expression of TrkC (NTRK3) in human soft tissue tumours. J Pathol 2002; 197: 661-667